| Ytd | 93.91% | |
| 1y | 208.29% |
| Open | 13.48 | Prev Close | 13.18 | Low | 13.20 | High | 13.69 | Mkt Cap | 1.81B |
| Vol | 0.00 | Avg Vol | 4.06M | EPS | -3.15 | P/E | -4.25 | Forward P/E | -9.20 |
| Beta | 2.50 | Short Ratio | 3.15 | Inst. Own | 71.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 12.59 | 200-d Avg | 8.42 | 1yr Est | 23.75 |
CMPS News
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec
COMPASS Pathways plc (CMPS) Q2 2026 Earnings Call Transcript
Compass Pathways NASDAQ: CMPS said it remains on track to complete its new drug application, or NDA,
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec
One of Cathie Wood's funds just sold some AtaiBeckley shares. It also bought some Compass Pathways s
CMPS leads regulated psilocybin with two successful Phase 3 trials and a rolling FDA submission, giv
Robinhood Markets Inc. (NASDAQ: HOOD) stock declines on Thursday due to tech market pullbacks, recen
Cathie Wood sold $10M of Robinhood while adding $15M to SpaceX and boosting Archer Aviation. Here
Compass Pathways (NASDAQ: CMPS - Get Free Report) is expected to release its Q2 2026 results before
BTIG initiates coverage on Neuronetics (STIM) with a Buy rating and $5 target as shares surge 28%. R
Compass Pathways (NASDAQ:CMPS)'s COMP360 treatment model may face fewer regulatory hurdles as new Ph
Compass Pathways (NASDAQ:CMPS)'s COMP360 treatment model may face fewer regulatory hurdles as new Ph
GH Research and Definium Therapeutics stocks rose after Eli Lilly agreed to buy AtaiBeckley in a dea
Post-hoc analysis of support methods used in an open-label Phase 2 COMP360 study showed monitoring a
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec
JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7
Psychedelic drug developers including AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC), Compass Pathways (N
CleanSpark Inc (NASDAQ:CLSK) shares surged more than 12% after the company announced a 20-year lease
Tower Semiconductor (NASDAQ:TSEM) shares rose 13% on Tuesday after the company announced a strategic
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Compass Pathways NASDAQ: CMPS said new 26-week data from its Phase 3 COMP006 trial further support t
Compass Pathways: 'Strong Buy' COMP360 Trial Wins And Q4 NDA Full Submission
COMPASS Pathways plc (CMPS) Discusses Six-Month Data from Second Phase 3 Trial Confirming Rapid and
Compass Pathways plc (NASDAQ:CMPS) on Wednesday reported 26-week results from Part B of its Phase 3
Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $
Health officials explored restricting specific antidepressants among SSRI drugs-sources
https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-ex
Nektar Therapeutics (NASDAQ: NKTR) rose on positive results for alopecia treatment. Other top gainer
Psychedelic drug maker shares jumped in Monday pre-market after an order from President Donald Trump
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $1
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
https://www.marijuanamoment.net/bipartisan-senators-file-bill-to-support-psychedelics-research-and-t
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the